CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C18804 | BRD-K51390731 | BRD-K51390731 | -- | -- | -- | Details |
| C18805 | BRD-K51390937 | BRD-K51390937 | -- | -- | -- | Details |
| C18806 | BRD-K51392039 | BRD-K51392039 | -- | -- | -- | Details |
| C18807 | BRD-K51394868 | BRD-K51394868 | -- | -- | -- | Details |
| C18808 | BRD-K51395794 | BRD-K51395794 | -- | -- | -- | Details |
| C18809 | BRD-K51398207 | BRD-K51398207 | -- | -- | -- | Details |
| C18810 | BRD-K51399866 | BRD-K51399866 | -- | -- | -- | Details |
| C18811 | BRD-K51400578 | BRD-K51400578 | -- | -- | -- | Details |
| C18812 | BRD-K51410836 | BRD-K51410836 | -- | -- | -- | Details |
| C18813 | BRD-K51411441 | BRD-K51411441 | -- | -- | -- | Details |
| C18814 | BRD-K51413232 | BRD-K51413232 | -- | -- | -- | Details |
| C18815 | BRD-K51418105 | BRD-K51418105 | -- | -- | -- | Details |
| C18816 | BRD-K51418664 | mitomycin-c | -- | -- | -- | Details |
| C18817 | BRD-K51428159 | BRD-K51428159 | -- | -- | -- | Details |
| C18818 | BRD-K51431550 | BRD-K51431550 | -- | -- | -- | Details |
| C18819 | BRD-K51443908 | KU-C104486 | -- | -- | -- | Details |
| C18820 | BRD-K51446586 | BRD-K51446586 | -- | -- | -- | Details |
| C18821 | BRD-K51448234 | BRD-K51448234 | -- | -- | -- | Details |
| C18822 | BRD-K51454545 | BRD-K51454545 | -- | -- | -- | Details |
| C18823 | BRD-K51454562 | BRD-K51454562 | -- | -- | -- | Details |
| C18824 | BRD-K51454923 | BRD-K51454923 | -- | -- | -- | Details |
| C18825 | BRD-K51457407 | BRD-K51457407 | -- | -- | -- | Details |
| C18826 | BRD-K51461946 | BRD-K51461946 | -- | -- | -- | Details |
| C18827 | BRD-K51465424 | ritodrine | ADRB2 | Adrenergic receptor agonist | -- | Details |
| C18828 | BRD-K51471001 | demecarium | ACHE | Acetylcholinesterase inhibitor | -- | Details |
| C18829 | BRD-K51471107 | BRD-K51471107 | -- | -- | -- | Details |
| C18830 | BRD-K51475868 | BRD-K51475868 | -- | -- | -- | Details |
| C18831 | BRD-K51476772 | ST-638 | -- | -- | -- | Details |
| C18832 | BRD-K51485625 | ritonavir | CYP1A2; CYP3A7; CYP2B6; CYP2C19; CYP2C8; CYP2C9; CYP2D6; CYP2E1; CYP3A4; CYP3A5 | HIV protease inhibitor | -- | Details |
| C18833 | BRD-K51486818 | lazabemide | MAOB | Monoamine oxidase inhibitor | -- | Details |
| C18834 | BRD-K51490254 | BRD-K51490254 | -- | -- | -- | Details |
| C18835 | BRD-K51490301 | BRD-K51490301 | -- | -- | -- | Details |
| C18836 | BRD-K51490423 | BRD-K51490423 | -- | -- | -- | Details |
| C18837 | BRD-K51498205 | BRD-K51498205 | -- | -- | -- | Details |
| C18838 | BRD-K51498721 | BRD-K51498721 | -- | -- | -- | Details |
| C18839 | BRD-K51502220 | BRD-K51502220 | -- | -- | -- | Details |
| C18840 | BRD-K51502980 | BRD-K51502980 | -- | -- | -- | Details |
| C18841 | BRD-K51511759 | BRD-K51511759 | -- | -- | -- | Details |
| C18842 | BRD-K51512723 | BRD-K51512723 | -- | -- | -- | Details |
| C18843 | BRD-K51515697 | BRD-K51515697 | -- | -- | -- | Details |
| C18844 | BRD-K51520673 | BRD-K51520673 | -- | -- | -- | Details |
| C18845 | BRD-K51522005 | BRD-K51522005 | -- | -- | -- | Details |
| C18846 | BRD-K51525251 | BRD-K51525251 | -- | -- | -- | Details |
| C18847 | BRD-K51530321 | BRD-K51530321 | -- | -- | -- | Details |
| C18848 | BRD-K51535480 | BRD-K51535480 | -- | -- | -- | Details |
| C18849 | BRD-K51538472 | BRD-K51538472 | -- | -- | -- | Details |
| C18850 | BRD-K51541829 | Ro-25-6981 | GRIN2B | Monamine transporter modulator; Ionotropic glutamate receptor antagonist | -- | Details |
| C18851 | BRD-K51544265 | cabozantinib | FLT3; KDR; KIT; MET; RET; TEK | VEGFR inhibitor; RET tyrosine kinase inhibitor | -- | Details |
| C18852 | BRD-K51546355 | BRD-K51546355 | -- | -- | -- | Details |
| C18853 | BRD-K51556300 | BRD-K51556300 | -- | -- | -- | Details |
| C18854 | BRD-K51556413 | BRD-K51556413 | -- | -- | -- | Details |
| C18855 | BRD-K51556457 | BRD-K51556457 | -- | -- | -- | Details |
| C18856 | BRD-K51557114 | BRD-K51557114 | -- | -- | -- | Details |
| C18857 | BRD-K51566146 | BRD-K51566146 | -- | -- | -- | Details |
| C18858 | BRD-K51566491 | BRD-K51566491 | -- | -- | 375_5632_4252_8463_6214 | Details |
| C18859 | BRD-K51568355 | BRD-K51568355 | -- | -- | -- | Details |
| C18860 | BRD-K51569524 | BRD-K51569524 | -- | -- | -- | Details |
| C18861 | BRD-K51572611 | BRD-K51572611 | -- | -- | -- | Details |
| C18862 | BRD-K51573654 | BRD-K51573654 | -- | -- | -- | Details |
| C18863 | BRD-K51574318 | BRD-K51574318 | -- | -- | -- | Details |
| C18864 | BRD-K51575138 | TPCA-1 | IKBKB | IKK inhibitor | -- | Details |
| C18865 | BRD-K51577368 | BRD-K51577368 | -- | -- | -- | Details |
| C18866 | BRD-K51577639 | BRD-K51577639 | -- | -- | -- | Details |
| C18867 | BRD-K51579714 | BRD-K51579714 | -- | -- | -- | Details |
| C18868 | BRD-K51579715 | BRD-K51579715 | -- | -- | -- | Details |
| C18869 | BRD-K51583960 | SA-1456443 | -- | -- | -- | Details |
| C18870 | BRD-K51585944 | BRD-K51585944 | -- | -- | -- | Details |
| C18871 | BRD-K51592421 | BRD-K51592421 | -- | -- | -- | Details |
| C18872 | BRD-K51592837 | BRD-K51592837 | -- | -- | -- | Details |
| C18873 | BRD-K51595563 | BRD-K51595563 | -- | -- | -- | Details |
| C18874 | BRD-K51600962 | BRD-K51600962 | -- | -- | -- | Details |
| C18875 | BRD-K51608228 | BRD-K51608228 | -- | -- | -- | Details |
| C18876 | BRD-K51608472 | BRD-K51608472 | -- | -- | -- | Details |
| C18877 | BRD-K51608872 | BRD-K51608872 | -- | -- | -- | Details |
| C18878 | BRD-K51620275 | BRD-K51620275 | -- | -- | -- | Details |
| C18879 | BRD-K51626376 | BRD-K51626376 | -- | -- | -- | Details |
| C18880 | BRD-K51633576 | BRD-K51633576 | -- | -- | -- | Details |
| C18881 | BRD-K51640940 | BRD-K51640940 | -- | -- | -- | Details |
| C18882 | BRD-K51641263 | BRD-K51641263 | -- | -- | -- | Details |
| C18883 | BRD-K51643438 | BRD-K51643438 | -- | -- | -- | Details |
| C18884 | BRD-K51643619 | BRD-K51643619 | -- | -- | -- | Details |
| C18885 | BRD-K51643793 | BRD-K51643793 | -- | -- | -- | Details |
| C18886 | BRD-K51644197 | BRD-K51644197 | -- | -- | -- | Details |
| C18887 | BRD-K51654114 | BRD-K51654114 | -- | -- | -- | Details |
| C18888 | BRD-K51662742 | BRD-K51662742 | -- | -- | -- | Details |
| C18889 | BRD-K51662849 | ilomastat | -- | -- | -- | Details |
| C18890 | BRD-K51666223 | BRD-K51666223 | -- | -- | -- | Details |
| C18891 | BRD-K51670762 | BRD-K51670762 | -- | -- | -- | Details |
| C18892 | BRD-K51671335 | levosulpiride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
| C18893 | BRD-K51674646 | BRD-K51674646 | -- | -- | -- | Details |
| C18894 | BRD-K51677086 | erythromycin-ethylsuccinate | CYP3A4; CYP51A1; ALB; MLNR; KCNH2; ABCB1; SLC47A1 | NFKB pathway inhibitor; Motilin receptor agonist; Cytochrome P450 inhibitor; Protein synthesis inhibitor | -- | Details |
| C18895 | BRD-K51681402 | BRD-K51681402 | -- | -- | -- | Details |
| C18896 | BRD-K51683034 | BRD-K51683034 | -- | -- | -- | Details |
| C18897 | BRD-K51696048 | BRD-K51696048 | -- | -- | -- | Details |
| C18898 | BRD-K51697315 | BRD-K51697315 | -- | -- | -- | Details |
| C18899 | BRD-K51697562 | BRD-K51697562 | -- | -- | -- | Details |
| C18900 | BRD-K51703152 | BRD-K51703152 | -- | -- | -- | Details |
| C18901 | BRD-K51704689 | BG-1031 | -- | -- | -- | Details |
| C18902 | BRD-K51707293 | BRD-K51707293 | -- | -- | -- | Details |
| C18903 | BRD-K51712294 | BRD-K51712294 | -- | -- | -- | Details |